INTRODUCTION
Although appropriate drug therapy can reduce morbidity, at times the use of a drug in a specific situation may be considered inappropriate -when the risks associated with the drug usage outweigh the beneÞ ts. Adverse events (AEs) negatively impact the quality of life and can at times be fatal. They cause clinically signiÞ cant morbidity and mortality and are associated with large economic costs. [1, 2] AEs are common across age groups, though the predominant drug class causing the AE in a particular age group may vary. Several studies have shown that the incidence of AEs is higher in elderly [3] [4] [5] and is associated with several factors, one of which is polypharmacy. A study in 1997 found that 35% of ambulatory older adults experienced an AE, and 29% required health care services (physician, emergency department visit or hospitalization) for the same. [6] Polypharmacy is associated with an increase in drug interactions, noncompliance and adverse events, which in turn leads to increase in hospital admissions and thus increased expenditure on health care. [7, 8] Several studies have attributed polypharmacy in elderly to factors such as age, multiple diseases, recent hospitalization, female sex, depression and the number of physicians prescribing drugs to the elderly. [9] Another important factor accounting for higher incidence of AEs in elderly is the use of drugs that may be inappropriate for them. AEs occurring as a result of inappropriate medication (IM) usage are increasingly becoming the focus of researchers. In 1992, Lindley et al. demonstrated the relation between inappropriate drug prescribing and AEs in elderly. They found that nearly 50% of the AEs in elderly were due to drugs that were contraindicated for use in them. [10] Around the same time, Beers et al. prepared a list of drugs inappropriate for use in elderly. A panel of experts consisting of geriatricians and pharmacologists headed by Mark Beers used a two-round survey based on the modiÞ ed Delphi technique and prepared the original Beers criteria in 1991. [11] The original list was only for elderly residing in nursing homes. It was later updated twice, in 1997 and 2003, to include all elderly. [12, 13] Over the years, authors have demonstrated a positive correlation between inappropriate medication use as per Beers criteria and increased utilization of health care services, [14] [15] [16] [17] leading to increased health care expenditure. [14, 18] Studies on AEs and adverse drug reactions (ADRs) from India mostly assess their nature, incidence, severity, causality, preventability and economic burden. [19] [20] [21] [22] None of the reports have any special focus on AEs in elderly and their correlation with inappropriate drug prescribing. This paper is a retrospective analysis of AE data collected at Seth G.S. Medical College and K.E.M. Hospital, Mumbai (Bombay), a tertiary care hospital in western India. The data was evaluated for the number of AEs in elderly, and the Beers criteria were applied to assess appropriateness of medication prescription in them preceding the AE.
MATERIALS AND METHODS

DeÞ nitions
Adverse events (AEs) and adverse drug reactions (ADRs) are two terms that are often used interchangeably in day-to-day practice. Both were defined as per the ICHE6R1 guideline. An adverse event was defined as "any untoward medical occurrence with a medicinal product in a patient or a clinical investigation, whether or not considered causally related." [23] An adverse drug reaction was deÞ ned as "a response to a drug which is noxious and unintended and which occurs at doses normally used in man for prophylaxis, diagnosis or therapy of disease or for the modiÞ cation of physiological function." [23, 24] It refers to harm directly caused by a drug at normally used doses.
Study methodology
The AE data used in our study was collected at the Department of Clinical Pharmacology, KEM Hospital, between January 2005 and December 2006. This data represents patients presenting to the outpatient and emergency department with an AE and also includes AEs noted in inpatients to medications administered while in the hospital. These AEs were reported spontaneously by the treating physicians. Other than that, our resident doctors personally visited various departments on a periodic basis and collected AE data. The AE was reported in a Suspected AE Reporting form available on the website of Central Drugs Standard Control Organization (CDSCO) to ensure uniformity in the process of data collection. [25] Elderly was deÞ ned as those aged ≥58 years. Since our life expectancy is lesser than that in developed countries, a cutoff of 65 years would considerably decrease the size of our study population. Thus, we did not use the cutoff of ≥65 years. [26] found that 3.6% of the AEs leading to emergency department visits in elderly aged 65 years and above were due to drugs not fulÞ lling Beers criteria. Thus, a small proportion of the AEs in elderly were due to medications not fulÞ lling Beers criteria. Furthermore, Budnitz also showed that although the medications not fulÞ lling Beers criteria caused 3.6% of the AEs, nearly 10.5% of the elderly were prescribed drugs inappropriate for them. [26] Numerous studies from various countries have similarly attributed AEs in elderly to IM usage. [26] [27] [28] • Central nervous system drugs • Cardiovascular drugs (15.2) • Antitubercular drugs • Anticoagulants (12.4) • Antimicrobial drugs • Central nervous system drugs (11.4) • Anticoagulants • Antitubercular drugs (8.6) • Nonsteroidal anti-inß ammatory drugs Top 5 drugs causing adverse events (%) Top 5 drugs causing adverse events • Oral sulfonylureas (15.2) • Phenytoin (12.1) • Warfarin (11.4) • Warfarin (8.7) • Insulin (8.6) • Beta lactams (4.9) • Phenytoin (7.6)
RESULTS
• Chloroquine (5.2) • Digoxin (5.7)
• Carbamazepine (3.1)
Researchers over the last 15 years have documented widespread IM use by elderly persons in hospitals, [28] nursing homes, [29] board and care facilities, [30] physician office practices, [31] hospital outpatient departments [32] and by homebound elderly, [33] with an estimated prevalence of potentially IM use of 12% to 40%. IM usage is ultimately a function of the number of drugs used. Thus, polypharmacy is the main risk factor for both IM usage and AEs in elderly. [34] In fact, Laroche et al. were of the opinion that polypharmacy is the main AE-facilitating factor, whereas IM usage is a subordinate factor. [35] In our study, there was no data available on drug prescriptions of elderly patients developing the reported AEs, as a result of which we are unable to produce data of the number of drugs used and IM usage by them.
Due to the retrospective nature of this study, we are unable to compute prevalence of AEs in elderly. Also, the Beers criteria deÞ ne elderly individuals as those aged 65 years and above. [13] However, the United Nations have not put forth any standard criterion for deÞ ning elderly. In most countries, the age at which an individual retires and is eligible to receive pension beneÞ ts is considered as the cutoff for deÞ ning elderly individuals. Thus in our study, we used a cutoff of 58 years. [36] In 2005, 6 of the 7 AEs attributed to drugs not fulfilling Beers criteria were due to digoxin. As per Beers criteria, Digoxin is considered inappropriate for use in elderly only in speciÞ c circumstances, i.e., when it is used above a dose of 0.125 mg/day except when it is used to treat atrial arrhythmias. [16] Certain drug classes like antidiabetics, oral anticoagulants and antiplatelets and narrow-therapeutic index drugs accounted for almost two thirds of the AEs in elderly; and of them, warfarin, digoxin and insulin causing a fourth of the AEs in elderly, which is, again, quite similar to the Þ ndings of Budnitz et al. Considering the extensive usage of these medications, it would be safe to assume that greater care observed while prescribing them would translate into a much greater decrease in AEs in elderly, leading to a substantial decrease in morbidity and mortality and thus a decrease in health care expenditure. Antitubercular drugs, which are used a lot more often than in western countries, are also important contributors to AEs in elderly, considering their weaker bodies and decreased organ reserve.
However, this study has several limitations. Data has been collected from a tertiary referral center, where on an average, more serious patients are seen. Secondly, due to lack of data on drug prescriptions, we cannot comment on the prevalence of inappropriate drug prescription in elderly and AEs resulting from inappropriate medications. Also, data regarding number of drugs used in a person are not available. Third, according to our understanding, the number of AEs is grossly under-reported. Fourth, the data was collected from the single-page AE form of the CDSCO, which is filled in by the physicians. So the completeness of the data in terms of the indication for drug use, dosage and route was dependent on the data Þ lled in by them. The identiÞ cation and reporting of an AE is also dependent to a huge extent on information shared by the patient regarding drug usage.
To conclude, adverse events are a major ADVERSE EVENTS IN ELDERLY cause of morbidity in the elderly. Some of the commonly used medications in elderly account for a significant proportion of AEs in them. While medications considered inappropriate on the basis of Beers criteria may not be accounting for a significant proportion of the AEs, it must be realized that simply a knowledge of such medications and avoiding their usage would Þ nally contribute to decreased AE-related health care outcomes. Prospective studies of a similar nature from India would help us quantify the extent of IM prescription and AE burden in elderly. It would also help in the establishment of criteria guiding drug prescription in elderly in a developing country like India.
